Cytotoxicity of diethyldithiocarbamate in human versus rodent cell lines Justin D. CohenH. Ian Robins Preclinical Studies Pages: 137 - 142
In vitro activity of 4′ -iodo-4′ -deoxydoxorubicin on human colo-rectal cancer as measured by a short-term antimetabolic assay Raffaella VillaNadia ZaffaroniRosella Silvestrini Preclinical Studies Pages: 143 - 144
Antitumor effect of GPA1734 in rat Walker 256 carcinoma Eleftheria MissirlisGeorge KarakiulakisMichael E. Maragoudakis Preclinical Studies Pages: 145 - 147
In vivo and in vitro pharmacokinetics of 4,6-benzylidene-D-glucose (BG) in rats John M. DornishRolf O. LarsenErik O. Pettersen Preclinical Studies Pages: 149 - 157
A phase I and pharmacokinetic study of trimetrexate using a 24-hour continuous-infection schedule Carmen J. AllegraJean JenkinsGregory A. Curt Clinical Studies Pages: 159 - 166
Phase I evaluation of diaziquone in childhood cancer J. M. FallettaB. CushingR. A. Krance Clinical Studies Pages: 167 - 170
Phase I trial of tallysomycin S10b, a bleomycin analogue Frank P. PaolozziRobert C. GaverRobert L. Comis Clinical Studies Pages: 171 - 180
Phase II trial of sequential methotrexate and 5-fluorouracil with leucovorin in children with sarcomas Frank M. BalisAndrea GillespieDavid G. Poplack Preclinical Studies Pages: 181 - 182
Phase II study of n-methylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancer David S. EttingerDianne M. FinkelsteinJohn C. Ruckdeschel Clinical Studies Pages: 183 - 185
Phase II trial of carboplatin in patients with advanced melanoma Ephraim S. CasperDean Bajorin Clinical Studies Pages: 187 - 190
Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced epithelial ovarian cancer William P. McGuire IIIJohn A. BlessingAlan Munoz Clinical Studies Pages: 191 - 194
Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced squamous cancer of the cervix William P. McGuire IIIJohn A. BlessingMichael L. Berman Clinical Studies Pages: 195 - 197
Phase II study of Fludarabine Phosphate in multiple myeloma Eric H. KrautJohn J. CrowleySydney E. Salmon Preclinal Studies Pages: 199 - 200
Evaluation of carboplatin (NSC 241240) in patients with recurrent or metastatic renal cell carcinoma Donald L. TrumpPaul Elson Clinical Studies Pages: 201 - 203
5-Day vinblastine infusion for pancreatic adenocarcinoma Jerry T. GuyThomas FlemingJames F. Boyd Clinical Studies Pages: 205 - 206
Pirarubicin (4′-o-tetrahydropyranil-adriamycin) for treatment of advanced breast cancer Werner ScheithauerHelmut SamoniggHeinz Ludwig Clinical Studies Pages: 207 - 210
Hypersensitivity reactions to trimetrexate Jean L. GremSusan A. KingThomas D. Brown Clinical Studies Pages: 211 - 214
Ifosfamide and mesna in combination with other cytostatic drugs in the treatment of patients with advanced cancer Geoffrey FalksonMartin R. ChasenHendrè C. Falkson Clinical Studies Pages: 215 - 219
Clinical cardiotoxicity of esorubicin (4′-deoxydoxorubicin,DxDx): Prospective studies with serial gated heart scans and reports of selected cases Q. Scott RingenbergKathleen J. PropertMark Green Clinical Studies Pages: 221 - 226
Clinical toxicity associated with tiazofurin Jean L. GremLarry RubinsteinDale D. Shoemaker Clinical Studies Pages: 227 - 238